For example, the administration of miR-146a was found to reduce proinflammatory cytokines (TNF-α, IL-1β, and IL-1α) and inflammatory edema in an LPS-induced model of sepsis in rats by targeting the TLR-4/NFκB pathway [62]. This evidence concerns the gene IL1A and Sepsis.